U.S. FDA votes against immediate-release pain drug from maker of OxyContin

September 10, 2015 8:53 PM

12 0

U.S. FDA votes against immediate-release pain drug from maker of OxyContin

WASHINGTON -- Federal health advisers have overwhelmingly voted against a proposed painkiller from the maker of OxyContin due to risks of overdose.

Purdue Pharma is seeking FDA approval to market a harder-to-abuse version of the immediate-release drug oxycodone. The company already sells an extended-release formulation of the drug OxyContin, which is designed to thwart crushing or snorting.

Read more

To category page

Loading...